Literature DB >> 10979983

Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell.

L J Cooper1, K M Shannon, M R Loken, M Weaver, K Stephens, E L Sievers.   

Abstract

Children with neurofibromatosis type 1 (NF1) carry germline mutations in one allele of the NF1 gene and are predisposed to myeloid malignancies, particularly juvenile myelomonocytic leukemia (JMML). Disruption of the remaining NF1 allele can be found in malignant cells. Flow cytometric cell sorting techniques to isolate the malignant cell populations and molecular genetic methods to assay for somatic loss of the normal NF1 allele were used to study an unusual child with NF1 and JMML who subsequently had T-cell lymphoma. The data show that malignant JMML and lymphoma cells share a common loss of genetic material involving the normal NF1 gene and approximately 50 Mb of flanking sequence, suggesting that the abnormal T-lymphoid and myeloid populations were derived from a common precursor cell. These data support the hypothesis that JMML can arise in a pluripotent hematopoietic cell.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10979983

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation.

Authors:  Christian Peter Kratz; Michaela Nathrath; Peter Freisinger; Petra Dressel; Hans-Peter Assmuss; Cornelia Klein; Ayami Yoshimi; Stefan Burdach; Charlotte Marie Niemeyer
Journal:  Eur J Pediatr       Date:  2005-12-21       Impact factor: 3.183

2.  Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.

Authors:  Y Zhang; B R Taylor; K Shannon; D W Clapp
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver.

Authors:  Atsushi Takahashi; Ryouhei Tsutsumi; Ippei Kikuchi; Chikashi Obuse; Yasuhiro Saito; Azadeh Seidi; Robert Karisch; Minerva Fernandez; Taewoo Cho; Naomi Ohnishi; Orit Rozenblatt-Rosen; Matthew Meyerson; Benjamin G Neel; Masanori Hatakeyama
Journal:  Mol Cell       Date:  2011-07-08       Impact factor: 17.970

4.  Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal.

Authors:  Vivienne I Rebel; Andrew L Kung; Elizabeth A Tanner; Hong Yang; Roderick T Bronson; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

5.  Yolk sac erythromyeloid progenitors expressing gain of function PTPN11 have functional features of JMML but are not sufficient to cause disease in mice.

Authors:  Stefan P Tarnawsky; Momoko Yoshimoto; Lisa Deng; Rebecca J Chan; Mervin C Yoder
Journal:  Dev Dyn       Date:  2017-10-23       Impact factor: 3.780

6.  The genomic landscape of pediatric myelodysplastic syndromes.

Authors:  Jason R Schwartz; Jing Ma; Tamara Lamprecht; Michael Walsh; Shuoguo Wang; Victoria Bryant; Guangchun Song; Gang Wu; John Easton; Chimene Kesserwan; Kim E Nichols; Charles G Mullighan; Raul C Ribeiro; Jeffery M Klco
Journal:  Nat Commun       Date:  2017-11-16       Impact factor: 14.919

Review 7.  Physiological and Aberrant γ-Globin Transcription During Development.

Authors:  Gloria Barbarani; Agata Labedz; Sarah Stucchi; Alessia Abbiati; Antonella E Ronchi
Journal:  Front Cell Dev Biol       Date:  2021-04-01

8.  Oncogenic Kras initiates leukemia in hematopoietic stem cells.

Authors:  Amit J Sabnis; Laurene S Cheung; Monique Dail; Hio Chung Kang; Marianne Santaguida; Michelle L Hermiston; Emmanuelle Passegué; Kevin Shannon; Benjamin S Braun
Journal:  PLoS Biol       Date:  2009-03-17       Impact factor: 8.029

9.  Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice.

Authors:  Stefan P Tarnawsky; Wen-Mei Yu; Cheng-Kui Qu; Rebecca J Chan; Mervin C Yoder
Journal:  Oncotarget       Date:  2018-04-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.